Madeleine Roach News Today

Sanofi announces changes to its Executive Committee Paris, August 31st, 2023. Sanofi announces the following changes to its Executive Committee: Houman Ashrafian is appointed as Head of Research &...

BioPharma

Houman Ashrafian is joining as Sanofi’s EVP, head of R&D from his previous position at SV Health Investors.

Jim Schneider. He makes the move from M&T Realty Capital, after a prior stint with JLL. Also moving with him from M&T are Madeleine Roach, Brian Lorenz and Shawn Needham. The team brings expertise in agency lending from HUD, Freddie Mac, Fannie Mae, etc. Colliers Hal Collett said in a statement, “Jim and team are known for their ability to provide comprehensive and innovative solutions for structuring even the most complex transactions. This expansion of our services in the Pacific North...

Schneider Roach M&T Realty Capital Corporation announced that it last fall secured a refinancing loan for the St. Anne Nursing & Rehabilitation Center, in the Meadowbrook neighborhood in North Seattle. The approximately $3.1 million was secured via the national mortgage insurance program (Section 232) of the U.S. Department of Housing and Urban Development. The non-recourse loan carries a fixed rate of 2.68%, with a fully amortizing loan term. The funding was secured by Madeleine Roach and J...

Roach The local office of M&T Realty Capital Corp. announced that it recently secured nearly $40.5 million in federally backed loans for three multifamily properties in the Tri Cities, which have 612 units. The buildings and their San Francisco owner werent named. M&Ts Jim Schneider and Madeleine Roach secured the market-rate funding: one loan via Fannie Mae, under its DUS Choice Refinance program; and two via the U.S. Department of Housing and Urban Developments 223(f) insurance program. Th...